The term "rare tumors" describes cancers that are so rare in children that there are no established treatment standards and, mostly, no clinical studies for them. They include certain skin cancers, ENT tumors, colon cancer and female genital tumors.
Several of the KiTZ research groups work on the development of targeted treatment options, including rare tumors. Within the INFORM program, the tumors of children and adolescents who have relapsed after cancer are comprehensively molecularly studied. An accurate characterization of the tumor aids to combat the cancer as successfully as possible.